Template:Imipenem cilastatin: Difference between revisions
Jump to navigation
Jump to search
Created page with "{| style="margin: 0 0 3em 3em; border: 1px solid #696969; float: right; width:20em" cellpadding="0" cellspacing="0"; | style="padding: 0 5px; font-size: 100%; background:#6969..." |
Gerald Chi (talk | contribs) mNo edit summary |
||
(2 intermediate revisions by one other user not shown) | |||
Line 1: | Line 1: | ||
{| style="margin: 0 0 3em 3em; border: 1px solid #696969; float: right; width:20em" cellpadding="0" cellspacing="0"; | {| style="margin: 0 0 3em 3em; border: 1px solid #696969; float: right; width:20em" cellpadding="0" cellspacing="0"; | ||
! style="padding: 0 5px; font-size: 100%; background:#F8F8FF" align=center | '''''[[Imipenem cilastatin|{{fontcolor|#6C7B8B|Imipenem Cilastatin}}]]''''' | |||
|- | |- | ||
! style="padding: 0 5px; font-size: 85%; background: | ! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | PRIMAXIN<sup>®</sup> FDA Package Insert | ||
|- | |- | ||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Imipenem cilastatin description|Description]] | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Imipenem cilastatin description|Description]] | ||
Line 14: | Line 14: | ||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Imipenem cilastatin contraindications|Contraindications]] | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Imipenem cilastatin contraindications|Contraindications]] | ||
|- | |- | ||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Imipenem cilastatin warnings|Warnings | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Imipenem cilastatin warnings and precautions|Warnings and Precautions]] | ||
|- | |- | ||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Imipenem cilastatin adverse reactions|Adverse Reactions]] | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Imipenem cilastatin adverse reactions|Adverse Reactions]] | ||
|- | |- | ||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Imipenem cilastatin overdosage|Overdosage]] | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Imipenem cilastatin overdosage|Overdosage]] | ||
|- | |- | ||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Imipenem cilastatin dosage and administration|Dosage and Administration]] | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Imipenem cilastatin dosage and administration|Dosage and Administration]] | ||
Line 31: | Line 27: | ||
|- | |- | ||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Imipenem cilastatin how supplied|How Supplied]] | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Imipenem cilastatin how supplied|How Supplied]] | ||
|- | |- | ||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Imipenem cilastatin labels and packages|Labels and Packages]] | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Imipenem cilastatin labels and packages|Labels and Packages]] | ||
|- | |- | ||
|} | |} |